Literature DB >> 24009928

Steroid hormone receptors, MIB-1, p53, and c-erb-B2 expression on breast cancer: Comparison of immunohistochemistry on cell block and fine needle aspiration and tissue sample, in northwest Iran.

Keykhosro Mardanpour1, Mahtab Rahbar.   

Abstract

BACKGROUND: Fine-needle aspiration of breast cancer often provides moderate cellular material that is representative of the tumors. These samples can be used not only for cytological diagnosis but also to obtain information on the prognosis and likely response to therapy by using immunohistochemical staining studies.
METHODS: We assessed the degree of correlation between prognostic biologic markers by means immunohistochemistry (IHC) on cytoblock obtained from fine-needle aspiration (FNA) and immunohistochemical determination on their corresponding tissue sample of five markers; steroid hormone receptors, MIB-1 (Ki-67), p53, and c-erb-B-2 (Her2/neu) in 45 mastectomy of breast cancer.
RESULTS: Interobserver reproducibility ranged from 93 to 100%, depending on the marker. A good correlation was observed between immunostaining assessment on cytoblock and on their corresponding tumor tissues as follows: Ki-67 (87%), ER (80%), PR (93%), p53 (96%), and c-erb-B-2 (76%).
CONCLUSION: We conclude that cytoblock prepared from fine-needle aspiration specimens of breast cancer is a useful and noninvasive procedure when planning neoadjuvant treatment.

Entities:  

Keywords:  Breast cancer; C-erb-B2; Esteroid receptors; Fine-needle aspiration; Immunohistochemistry; Ki67; P53; cell block

Year:  2012        PMID: 24009928      PMCID: PMC3755861     

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  8 in total

1.  Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas. Results on six years of material and correlation with biochemical assay.

Authors:  T Sauer; E Beraki; P W Jebsen; E Amlie; T Harbitz; R Kåresen; O Naess
Journal:  Anal Quant Cytol Histol       Date:  1998-04       Impact factor: 0.302

2.  The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: method, preliminary results and prognostic associations.

Authors:  S E Pinder; P M Wencyk; H E Naylor; J A Bell; C W Elston; J F Robertson; R W Blamey; I O Ellis
Journal:  Cytopathology       Date:  1995-10       Impact factor: 2.073

3.  Cytological evaluation of biological prognostic markers from primary breast carcinomas.

Authors:  A Makris; D C Allred; T J Powles; M Dowsett; I N Fernando; P A Trott; S E Ashley; M G Ormerod; J C Titley; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1997-05       Impact factor: 4.872

4.  Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.

Authors:  M Briffod; K Hacène; V Le Doussal
Journal:  Mod Pathol       Date:  2000-08       Impact factor: 7.842

5.  Semiquantitative assessment of c-erbB-2 (HER-2) status in cytology specimens and tissue sections from breast carcinoma.

Authors:  C C Solomides; R Zimmerman; M Bibbo
Journal:  Anal Quant Cytol Histol       Date:  1999-04       Impact factor: 0.302

6.  Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma.

Authors:  C Lavarino; V Corletto; A Mezzelani; G Della Torre; C Bartoli; C Riva; M A Pierotti; F Rilke; S Pilotti
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

7.  Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma.

Authors:  C Bozzetti; R Nizzoli; N Naldi; L Manotti; L Savoldi; R Camisa; A Guazzi; G Cocconi
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods.

Authors:  Ali Montazeri; Mariam Vahdaninia; Iraj Harirchi; Amir Mahmood Harirchi; Akram Sajadian; Fatemeh Khaleghi; Mandana Ebrahimi; Shahpar Haghighat; Soghra Jarvandi
Journal:  Asia Pac Fam Med       Date:  2008-12-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.